Here’s why Appen (ASX:APX) crashed 30% today (and for the upteenth time in 3 years)

Nick Sundich Nick Sundich, August 28, 2023

Today Appen (ASX:APX) reported its 1HY23 results and once again investors received it poorly.

 

What are the Best Tech stocks to invest in right now?

Check our buy/sell stock tips

 

Who is Appen (ASX:APX)?

Appen sources and sells machine learning data to train AI algorithms. Historically, its client base was concentrated around a handful of big tech companies and predominantly for advertising purposes. But Appen has been diversifying its customer base into new clients and markets although investors fear these cash flows won’t be as reliable and as strong as before. This has been showing in its results and in repeated failure to meet its own guidance, let alone consensus estimates.

In FY22, which is the calendar year, its revenue fell by 25% and its bottom line swung from a $28m profit to a $239m loss.

In 2023, the stock has surpassed $3 on a couple of occasions over hype that it can capitalise on the rise of ChatGPT and hope that things can get better because of new management and a cost reduction program. But so far it is not showing in the bottom line.

In 1HY23, the company’s revenue declined 24% to US$138.9m, a fall management blamed on challenging external operating and macroeconomic conditions. It posted an underlying loss of US$34.2m and a statutory loss of US$43.3m.

Shares fell more than 30% on Monday to go even further away from its mid-2020 highs.

 

Appen (ASX:APX) share price chart, log scale (Source: TradingView)

 

Was the result that bad?

Considering the hype about AI, and the company’s explicit promise to capitalise on it, it probably is. What made things worse is that after previously promising that the second half would be better, the company expects the second half to be roughly the same. It also promised it would reach ‘underlying cash EBITDA profitability on an annualised, run-rate basis‘.

But it would likely surprise nobody (us included) if it was a further deterioration still.

 

Stocks Down Under Concierge is here to help you pick winning stocks!

The team at Stocks Down Under have been in the markets since the mid-90s and we have gone through many ups and downs. We have written about every sector, including Semiconductors!

Our Concierge BUY and SELL service picks the best stocks on ASX. We won’t just tell you what to buy – we give you a buy range, price target and stop loss level in order to maximise total returns. And we will only recommend very high conviction stocks where substantial due diligence has been conducted.

Our performance is well ahead of the ASX200 and All Ords.

You can try out Concierge … for FREE.

 

GET A FREE TRIAL TO CONCIERGE TODAY

 

There’s no credit card needed – the trial expires automatically.

 

 

Blog Categories

Get Our Top 5 ASX Stocks for FY25

Recent Posts

Paradigm Biopharmaceuticals

Paradigm Biopharmaceuticals (ASX:PAR): An osteoarthritis solution that could hit the market within 3 years

If you thought the were plenty of treatments for osteoarthritis already, Paradigm Biopharmaceuticals (ASX:PAR) is a company that has something…

Cann Group

Cann Group (ASX:CAN): Successfully producing GMP medicinal cannabis since 2017

Cann Group (ASX:CAN) is the first company in Australia that was issued a medicinal cannabis license, granted by the Australian…

CET1 ratio

CET1 ratio: If you invest in ASX bank stocks, here’s why it is an important metric to know

In this article we look at the Common Equity Tier 1 (CET1) ratio – what it is and why it…